IHC Marker-Smooth Muscle Myosin Test
About IHC Marker-Smooth Muscle Myosin Test
| Field | Value |
|---|---|
| Also Known As | SMMHC (Smooth Muscle Myosin Heavy Chain) test, SM-MHC, SMM, Smooth Muscle Myosin IHC, SMMS-1 |
| Sample Type | Formalin-fixed paraffin-embedded (FFPE) tissue block |
| Fasting Required | No—this test is performed on a tissue sample, not a blood sample |
| Report Time | 3 days |
| Recommended For | Individuals of all age groups when tissue differentiation is clinically required |
| Price | Starting at ₹1,920 |
What is an IHC Marker-Smooth Muscle Myosin Test?
The IHC marker-Smooth Muscle Myosin test is a specialised pathology test that detects the presence of smooth muscle myosin heavy chain (SMMHC) protein in tissue samples. It uses immunohistochemistry (IHC), a technique that applies a specific antibody to a tissue section to reveal whether a target protein is present. Doctors order this test to understand the nature of a tissue sample, particularly when a biopsy shows abnormal or unclear findings. The test is also referred to as the SMMS-1 IHC or SM-MHC test.
What Does an IHC Marker-Smooth Muscle Myosin Test Measure?
This test examines tissue sections for the presence and distribution of smooth muscle myosin heavy chain protein. The table below explains what the test looks for and why each finding matters.
| Component | What It Means |
|---|---|
| Smooth Muscle Myosin Heavy Chain (SM-MHC) | A structural protein in the contractile machinery of smooth muscle cells; its presence confirms smooth muscle or myoepithelial differentiation |
| SM1 and SM2 Isoforms | Two variants of the myosin heavy chain protein; both are identified in fixed tissue sections and help characterise cell type |
| Myoepithelial Cell Presence | Specialised contractile cells that line glandular tissue; their presence or absence is critical in breast pathology to distinguish benign from invasive lesions |
Why is an IHC Marker-Smooth Muscle Myosin Test Done?
This test is requested by pathologists and clinicians when tissue samples need further characterisation beyond routine examination.
Common Symptoms That May Require This Test
A doctor may request this test when a biopsy has already been performed and additional clarification is needed. Common clinical scenarios include:
- A breast lump or palpable mass that has been biopsied
- Abnormal findings on a routine tissue biopsy
- A suspected tumour requiring cell-type confirmation
- Unclear or inconclusive pathology findings on initial examination
- Suspected invasion in a breast lesion identified on biopsy
- A soft tissue tumour requiring further evaluation
Conditions This Test Can Help Detect
The IHC marker-Smooth Muscle Myosin test assists pathologists in screening or distinguishing a range of conditions. These include:
- Benign sclerosing breast lesions versus infiltrating (invasive) carcinomas
- Ductal carcinoma in situ (DCIS, a non-invasive form of breast cancer) versus invasive breast cancer
- Smooth muscle cell tumours and myoepithelial tumours
- Muscle differentiation in tumours such as leiomyoma and leiomyosarcoma
How to Prepare and What to Expect
This test is performed on a tissue block in the laboratory. The patient does not need to visit the lab for the IHC testing itself, though a biopsy procedure is required to obtain the sample.
Do You Need to Fast?
No fasting is required for this test. The analysis is carried out on a tissue sample, not a blood or urine sample. If your doctor has scheduled a biopsy under sedation or anaesthesia to collect the tissue, they will give you separate preparation instructions, which may include fasting guidelines.
Practical Tips Before Your Test
Before your biopsy or sample submission, keep the following in mind:
- Bring a detailed clinical history, including your symptoms, previous test results, and relevant medical records, as this is required for the test.
- Inform your doctor about any blood-thinning medications you take, as these may increase bleeding risk during the biopsy.
- Mention any allergies, bleeding disorders, or whether you are pregnant, so your doctor can plan the biopsy safely.
- Carry previous biopsy reports or imaging results to your consultation.
Step-by-Step Procedure
The IHC marker-Smooth Muscle Myosin test procedure involves the following steps:
- A doctor performs a biopsy to collect a tissue sample from the area of concern. The method (needle biopsy or excisional biopsy) depends on the clinical situation.
- The collected tissue is fixed in formalin to preserve its cellular structure, then embedded in paraffin wax to create a firm block (the FFPE tissue block).
- The laboratory cuts very thin sections (5 microns) from the paraffin block and places them on glass slides.
- A specific antibody linked to a visible dye is applied to the tissue section. When the antibody binds to the smooth muscle myosin protein, the dye becomes visible under a microscope.
- A qualified pathologist examines the stained slides under a light microscope, assessing the pattern, location, and intensity of staining.
- The pathologist prepares a report interpreting the findings in the context of the clinical history and other laboratory results.
Factors That Can Affect Accuracy
Several factors can influence the reliability of the test result:
- Quality and size of the tissue sample collected during biopsy
- Proper tissue processing and preparation of the paraffin block
- Quality of the antibody reagent used in the laboratory
- Availability of appropriate positive and negative control samples
- Pathologist experience in interpreting IHC staining patterns
Understanding Your IHC Marker-Smooth Muscle Myosin Test Results
Results from this test are qualitative rather than numerical. A qualified pathologist reports whether the staining is positive or negative, along with the intensity and distribution. The table below provides a general guide to interpretation.
| Result | Pattern | Typical Significance |
|---|---|---|
| Positive staining | Cytoplasmic staining in spindle cells surrounding glandular tissue | Myoepithelial cell layer is intact; consistent with benign or in situ lesions. |
| Negative staining | No staining detected in cells of interest | Loss of myoepithelial layer; may suggest invasive carcinoma. Further evaluation may be needed. |
Disclaimer: These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
How to Maintain Healthy Levels
This is a diagnostic marker used in pathology, not a routine wellness test. The concept of maintaining healthy levels does not apply. General guidance includes:
- Follow your treating doctor's guidance regarding any diagnosed condition and attend all recommended follow-up appointments.
- Maintain regular health screenings as advised by your doctor, particularly if you have a personal or family history of breast or soft tissue conditions.
- Keep records of your biopsy reports and IHC results for future clinical consultations.
Lupin Diagnostics IHC Marker-Smooth Muscle Myosin Test Price
The IHC marker-Smooth Muscle Myosin test cost at Lupin Diagnostics starts at ₹1,920. This test requires a visit to a Lupin Diagnostics centre; home collection is not available, as the test is performed on a tissue block obtained through a biopsy.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 1920 |
| CHENNAI | 1920 |
| HYDERABAD | 1920 |
| KOLKATA | 1920 |
| NAVI MUMBAI | 1920 |
| PUNE | 1920 |
Disclaimer: Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time for sample submission (FFPE tissue block or prepared slides).
- Receive your report via email or WhatsApp within 3 days.
Frequently Asked Questions
This test detects smooth muscle myosin heavy chain protein in tissue samples. It helps pathologists distinguish between benign breast lesions and invasive carcinomas, and also assists in identifying smooth muscle and myoepithelial tumours. It is typically ordered after a biopsy when further tissue characterisation is needed.
The tissue sample is obtained through a biopsy performed by a doctor. The method depends on the clinical situation and may include a needle biopsy or a surgical (excisional) biopsy. The collected tissue is then processed into an FFPE tissue block, which is sent to the laboratory for the IHC marker-Smooth Muscle Myosin test procedure.
This marker is highly useful, but pathologists often use a panel of two or more markers together for greater accuracy. Other markers such as calponin and p63 may be used alongside smooth muscle myosin heavy chain to improve the confidence of interpretation.
No special preparation is needed for the IHC analysis itself. If you have not yet had your biopsy, your doctor will provide specific instructions about medications to pause and whether fasting is needed if sedation will be used during the procedure.
Yes, this is one of the primary uses of the test. Positive staining indicates that the myoepithelial cell layer is intact, which is typically seen in benign and non-invasive breast lesions. Negative staining may indicate loss of this layer, a feature often associated with invasive breast cancer. However, the result must always be interpreted along with other pathology findings and the patient's clinical history.
A detailed clinical history is required for this test. Bring your previous biopsy reports, imaging results, and a summary of your symptoms and medical background. This information helps the pathologist interpret the staining pattern accurately and in the correct clinical context.
IHC Marker-Smooth Muscle Myosin Test
